2023
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis
Omran S, Shu L, Chang A, Parikh N, Zubair A, Simpkins A, Heldner M, Hakim A, Al Kasab S, Nguyen T, Klein P, Goldstein E, Vedovati M, Paciaroni M, Liebeskind D, Yaghi S, Cutting S. Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis. Journal Of Stroke 2023, 25: 291-298. PMID: 37282376, PMCID: PMC10250867, DOI: 10.5853/jos.2023.00213.Peer-Reviewed Original ResearchCerebral venous thrombosisPredictors of recanalizationVenous thrombosisMale sexMultivariable analysisParenchymal changesOlder ageTiming of recanalizationVenous thrombosis studyLarge prospective studiesCVT diagnosisFurther recanalizationComplete recanalizationAnticoagulation treatmentConsecutive patientsDisease courseIndependent predictorsVessel recanalizationBaseline imagingInitial diagnosisMedian timeProspective studyPrespecified variablesThrombosis StudyFavorable outcome
2022
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study
Yaghi S, Shu L, Bakradze E, Omran S, Giles JA, Amar JY, Henninger N, Elnazeir M, Liberman AL, Moncrieffe K, Lu J, Sharma R, Cheng Y, Zubair AS, Simpkins AN, Li GT, Kung JC, Perez D, Heldner M, Scutelnic A, Seiffge D, Siepen B, Rothstein A, Khazaal O, Do D, Al Kasab S, Rahman LA, Mistry EA, Kerrigan D, Lafever H, Nguyen TN, Klein P, Aparicio H, Frontera J, Kuohn L, Agarwal S, Stretz C, Kala N, Jamal S, Chang A, Cutting S, Xiao H, de Havenon A, Muddasani V, Wu T, Wilson D, Nouh A, Asad SD, Qureshi A, Moore J, Khatri P, Aziz Y, Casteigne B, Khan M, Cheng Y, Mac Grory B, Weiss M, Ryan D, Vedovati MC, Paciaroni M, Siegler JE, Kamen S, Yu S, Guerrero C, Atallah E, De Marchis GM, Brehm A, Dittrich T, Psychogios M, Alvarado-Dyer R, Kass-Hout T, Prabhakaran S, Honda T, Liebeskind DS, Furie K. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke 2022, 53: 728-738. PMID: 35143325, DOI: 10.1161/strokeaha.121.037541.Peer-Reviewed Original ResearchConceptsCerebral venous thrombosisDirect oral anticoagulantsVenous thrombosisRecurrent venous thrombosisMajor hemorrhageInclusion criteriaDirect Oral Anticoagulants Versus WarfarinMulticenter international retrospective studyInverse probabilityInternational retrospective studySystemic venous thrombosisFavorable safety profileCox regression modelMulticenter international studyAnalysis inclusion criteriaBaseline imaging dataCVT patientsOral anticoagulationComplete recanalizationDOAC treatmentOral anticoagulantsRadiological outcomesRadiographic outcomesVersus WarfarinWarfarin treatment